ADC Therapeutics SAADCT
紐約證券 · USD
1.07
-0.04
(-3.60%)
收盤 09/12 03:59 (UTC+8)
09/12 03:59 (UTC+8)
ADC Therapeutics SAADCT
1.07
-0.04
(-3.60%)
財務數據
損益表
- 0.18
- 0.17
- 0.18
- 0.17
- 0.23
- 0.19
- 0.16
- 0.23
- 0.21
- 0.19
- 7.52
- -3.56
- 6.05
- -8.42
- 36.21
- -18.21
- -12.80
- 40.37
- -9.57
- -7.69
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 19,248 | 20,851 | 23,058 | 16,427 | 18,839 | 23,033 | 16,910 | 18,464 | 17,410 | 18,053 |
營業成本 | 2,349 | 3,615 | 1,699 | 1,202 | 836 | 2,061 | 1,371 | 851 | 1,217 | 2,510 |
營業毛利 | 16,899 | 17,236 | 21,359 | 15,225 | 18,003 | 20,972 | 15,539 | 17,613 | 16,193 | 15,543 |
營業費用 | 42,313 | 42,481 | 39,278 | 46,194 | 62,150 | 49,436 | - | - | 45,234 | - |
研發費用 | 17,366 | 19,877 | 18,184 | 26,803 | 30,090 | 28,928 | 27,101 | 32,502 | 24,295 | 25,735 |
推銷及管理費用 | 22,273 | 22,604 | 21,442 | 19,014 | 18,969 | 20,508 | 20,874 | 20,675 | 20,939 | 23,421 |
非經常性項目費用 | 2,674 | - | -348 | 377 | 13,091 | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -22,778 | -25,245 | -18,123 | -30,969 | -44,147 | -28,464 | -32,436 | -35,564 | -29,041 | -33,613 |
其他收入及費用 | 22,357 | 4,626 | 24,120 | 3,395 | 1,752 | 2,257 | 13,307 | 5,062 | 6,007 | 353 |
利息費用 | 13,508 | 12,349 | 13,014 | 13,392 | 12,997 | 12,230 | 11,919 | 13,117 | 12,679 | 12,496 |
稅前純益 | -16,565 | -32,968 | -6,813 | -40,966 | -55,392 | -38,437 | -31,048 | -43,619 | -35,713 | -45,756 |
所得稅 | - | - | -404 | - | 1,254 | 165 | -321 | 90 | 234 | 163 |
稅後純益 | -16,565 | -32,968 | -6,409 | -40,966 | -56,646 | -38,602 | -30,727 | -43,969 | -36,544 | -46,606 |
基本每股稅後盈餘(元) | -0.11 | -0.21 | -0.04 | -0.30 | -0.50 | -0.36 | -0.29 | -0.42 | -0.38 | -0.56 |
稀釋每股稅後盈餘(元) | -0.11 | -0.21 | 0.02 | -0.28 | -0.50 | -0.36 | -0.27 | -0.42 | -0.37 | -0.56 |
基本平均股數(千股) | 155016.00 | 154142.00 | 150301.00 | 136446.00 | 113743.00 | 107202.00 | 105396.00 | 104824.00 | 95691.00 | 82552.00 |
稀釋平均股數(千股) | 155016.00 | 154142.00 | 150301.00 | 136446.00 | 113743.00 | 107202.00 | 105396.00 | 104824.00 | 95691.00 | 82552.00 |
還原基本每股稅後盈餘(元) | -0.11 | -0.21 | -0.04 | -0.30 | -0.50 | -0.36 | -0.29 | -0.42 | -0.38 | -0.56 |
還原稀釋每股稅後盈餘(元) | -0.11 | -0.21 | 0.02 | -0.28 | -0.50 | -0.36 | -0.27 | -0.42 | -0.37 | -0.56 |
還原基本平均股數(千股) | 155,016 | 154,142 | 150,301 | 136,446 | 113,743 | 107,202 | 105,396 | 104,824 | 95,691 | 82,552 |
還原稀釋平均股數(千股) | 155,016 | 154,142 | 150,301 | 136,446 | 113,743 | 107,202 | 105,396 | 104,824 | 95,691 | 82,552 |
EBITDA(千元) | 5,133 | -13,441 | 14,344 | -17,678 | -33,684 | -18,146 | -11,633 | -22,270 | -15,427 | -25,737 |